» Articles » PMID: 38408228

Adherence to a Reproductive Health Intervention for Young Adults with Sickle Cell

Overview
Publisher Wolters Kluwer
Specialty Nursing
Date 2024 Feb 26
PMID 38408228
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The CHOICES intervention is tailored specifically for young adults with sickle cell disease (SCD) or sickle cell trait (SCT). The face-to-face (F2F) delivery format is feasible with efficacy for improving knowledge about reproductive health for those with SCD or SCT.

Purpose: The purpose of the study was to compare the participant adherence to a remote online CHOICES intervention study ( N = 107) and a F2F CHOICES intervention study ( N = 234).

Methodology: In both studies, participants with SCD or SCT were randomized into experimental or usual care control groups. Descriptive statistics were collected for all participants by group in both studies. Adherence was measured by retention at each data collection time point. Independent t -tests were conducted to compare mean participant adherence of the F2F and online studies postbaseline (6, 12, 18, and 24 months).

Results: There was a significant difference in mean adherence postbaseline between the studies ( p = .005). The results suggest that more research is necessary for proper online participant retention.

Conclusion: Advance practice nurses that are well informed on CHOICES can transmit the availability of this evidence-based intervention to this special population. Special referral for the CHOICES intervention, which is tailored specifically for young adults with SCD or SCT, may increase adherence to the intervention if it comes from trusted health care providers.

Implications: Nurse practitioners are educators in primary and acute care settings. Encounters with reproductive age populations with SCD or SCT can occur in both settings.

References
1.
Beintner I, Vollert B, Zarski A, Bolinski F, Musiat P, Gorlich D . Adherence Reporting in Randomized Controlled Trials Examining Manualized Multisession Online Interventions: Systematic Review of Practices and Proposal for Reporting Standards. J Med Internet Res. 2019; 21(8):e14181. PMC: 6713038. DOI: 10.2196/14181. View

2.
Gallo A, Wilkie D, Yao Y, Molokie R, Stahl C, Hershberger P . Reproductive Health CHOICES for Young Adults with Sickle Cell Disease or Trait: Randomized Controlled Trial Outcomes over Two Years. J Genet Couns. 2015; 25(2):325-36. PMC: 4769978. DOI: 10.1007/s10897-015-9874-0. View

3.
Mayo-Gamble T, Schlundt D, Cunningham-Erves J, McBride Murry V, Bonnet K, Quasie-Woode D . Sickle cell carriers' unmet information needs: Beyond knowing trait status. J Genet Couns. 2019; 28(4):812-821. PMC: 6679751. DOI: 10.1002/jgc4.1124. View

4.
Johnson-Mallard V, Oguntoye A, Eades N, Aldossary D, Kuenzli G, Ezenwa M . Development of an Online Reproductive Health Intervention for Individuals with Sickle Cell Disease or Trait. Womens Health Rep (New Rochelle). 2021; 2(1):142-148. PMC: 8140351. DOI: 10.1089/whr.2020.0098. View

5.
Hankins J, Shah N . Tackling adherence in sickle cell disease with mHealth. Lancet Haematol. 2020; 7(10):e713-e714. DOI: 10.1016/S2352-3026(20)30299-4. View